Oliver Godje, Chief Medical Officer of Sequana Medical, commented:”We are delighted to obtain clearance of the IND for our DSR 2.0 product andare ready to commence the MOJAVE study in US patients with …
Read Full Story at source (may require registration)
Turntide Gateshead Headquarters TheTurntide Gateshead Facility Alpharetta, GA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Turntide Technologies (Turntide) is pleased to...
One-year follow-up data confirm favorable safety profile of BellaSeno´s scaffolds compared to silicone implantsCompany plans expansion to primary breast augmentation...
Sustainability Economics Joins AIGCC Sustainability Economics proudly announces its membership in the Asia Investor Group on Climate Change (AIGCC). Singapore,...
14 JANUARY 2025 NORTHERN 2 VCT PLC OFFER FOR SUBSCRIPTION Further to the announcement made by Northern 2 VCT PLC...
14 JANUARY 2025 NORTHERN 3 VCT PLC OFFER FOR SUBSCRIPTION Further to the announcement made by Northern 3 VCT PLC...
14 JANUARY 2025 NORTHERN VENTURE TRUST PLC OFFER FOR SUBSCRIPTION Further to the announcement made by Northern Venture Trust PLC...
